Adalimumab biosimilar (Jiangsu Pacific-Meinuoke)
阿达木单抗生物类似药 (江苏太平洋美诺克)
Report date: 2022/01/14 13:23:58
Base Information
Drug NameAdalimumab biosimilar (Jiangsu Pacific-Meinuoke)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJiangsu Pacific Minok Biopharmaceutical Co., Ltd.
China Registration ClassN/A
Develop Information
Active CompaniesJiangsu Pacific Minok Biopharmaceutical Co., Ltd.
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A